Clinical Trial Update: Cilostazol in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cilostazol for Parkinson's disease, sponsored by Ain Shams University, is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Ain Shams University | Conditions: Parkinson's Disease | Phase 2 | Status: NOT_YET_RECRUITING